CS logo
small CS logo
Kailash Cancer Hospital And Research Center

Vadodara, Gujarat, India
Cancer treatment center in Gujarat
Muni Seva Ashram Goraj, Waghodia, Gujarat 391760

About Kailash Cancer Hospital And Research Center


"Kailash Cancer Hospital & Research Centre has provided the finest medical Care service to the people of Southeastern Gujarat. It is ranked as one of India's Leading Cancer Hospitals, based on the number of patients diagnosed and treated annually. The hospital is designed to provide curative and preventive treatment, post therapy support service, palliative care in hospice and domiciliary facility. Apart from Cancer treatment, it is the only facility in India to have a dedicated range of pediatric services. It is also know as best in class for: Gynecology & Obstetric General Surgery Critical Care Services Diabetes Treatment Urology Full time - Diagnostic Imaging / Radiology / 16 Slice C.T. Scan / X Ray departments"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Aurigene Discovery Technologies Limited
1
Ayana Pharma Ltd.,
1
CanariaBio Inc.
1
Gemin X
1
Mylan Pharmaceuticals Inc
1
Tata Memorial Hospital
1
mAbxience Research S.L.
1
Total Rows: 8

Clinical Trials at Kailash Cancer Hospital And Research Center


During the past decade, Kailash Cancer Hospital And Research Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2222000011111100001100110000Started TrialsCompleted Trails20172018201920202021202220230123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)
2008-05-01
2011-11-01
Completed
218
Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma
2013-05-01
2017-07-01
Completed
272
A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy
2017-09-11
2023-03-20
Active, not recruiting
453
A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer.
2018-08-29
2019-03-07
Completed
52
Adjuvant Radiotherapy in Early Stage Oral Cancers
2018-08-02
2026-09-30
Recruiting
392
MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC
2017-01-21
2019-11-22
Completed
671
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
2021-08-27
2033-11-21
Recruiting
4,100
First in Human, Dose Escalation, Dose Expansion Study of AUR105
2022-11-30
2026-05-30
Recruiting
40

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kailash Cancer Hospital And Research Center" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Aurigene Discovery Technologies Limited" with 1 trials sponsored, "Ayana Pharma Ltd.," with 1 trials sponsored, "CanariaBio Inc." with 1 trials sponsored and "Gemin X" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kailash Cancer Hospital And Research Center" #1 collaborator was "Actoverco" with 1 trials as a collaborator, "Cephalon" with 1 trials as a collaborator, "Innogene Kalbiotech Pte. Ltd" with 1 trials as a collaborator, "Key Oncologics (Pty) Ltd" with 1 trials as a collaborator and "Laboratorio Elea Phoenix S.A." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 2Hoffmann-La Roche: 2Aurigene DiscoveryTechnologies Limited: 1Aurigene DiscoveryTechnologies Limited: 1Ayana Pharma Ltd.,: 1Ayana Pharma Ltd.,: 1CanariaBio Inc.: 1CanariaBio Inc.: 1Gemin X: 1Gemin X: 1Mylan Pharmaceuticals Inc: 1Mylan Pharmaceuticals Inc: 1Tata Memorial Hospital: 1Tata Memorial Hospital: 1mAbxience Research S.L.: 1mAbxience Research S.L.: 1

Created with Highcharts 11.1.0Top CollaboratorsActoverco: 1Actoverco: 1Cephalon: 1Cephalon: 1Innogene Kalbiotech Pte. Ltd: 1Innogene Kalbiotech Pte. Ltd: 1Key Oncologics (Pty) Ltd: 1Key Oncologics (Pty) Ltd: 1Laboratorio Elea Phoenix S.A.: 1Laboratorio Elea Phoenix S.A.: 1Laboratorios deProductos ÉticosC.E.I.S.A.: 1Laboratorios deProductos ÉticosC.E.I.S.A.: 1Lambda TherapeuticResearch Ltd.: 1Lambda TherapeuticResearch Ltd.: 1Libbs Farmacêutica LTDA: 1Libbs Farmacêutica LTDA: 1NATIONAL CANCER GRID: 1NATIONAL CANCER GRID: 1Nanolek LLC: 1Nanolek LLC: 1

Clinical Trials Conditions at Kailash Cancer Hospital And Research Center


According to Clinical.Site data, the most researched conditions in "Kailash Cancer Hospital And Research Center" are "Buccal Mucosa Cancer" (1 trials), "Cancer of Mouth" (1 trials), "Cancer of the Head and Neck" (1 trials), "Cancer of the Tongue" (1 trials) and "Diffuse Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Kailash Cancer Hospital And Research Center" in a lesser frequency.

Clinical Trials Intervention Types at Kailash Cancer Hospital And Research Center


Most popular intervention types in "Kailash Cancer Hospital And Research Center" are "Drug" (6 trials), "Biological" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "AUR105" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials), "Bevacizumab as Avastin" (1 trials), "Bevacizumab as MYL-1402O" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kailash Cancer Hospital And Research Center


The vast majority of trials in "Kailash Cancer Hospital And Research Center" are 7 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Kailash Cancer Hospital And Research Center


Currently, there are NaN active trials in "Kailash Cancer Hospital And Research Center". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kailash Cancer Hospital And Research Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kailash Cancer Hospital And Research Center, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 1: 3Phase 1: 3Phase 2: 2Phase 2: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Recruiting: 4Recruiting: 4Active, not recruiting: 1Active, not recruiting: 1